Indications
As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight management programme which also includes appropriate dietary changes. Introducing appropriate lifestyle changes (e.g. increased exercise), in conjunction with this weight management programme, may provide additional benefits.
Composition
- Active substance
- mitratapide
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Yarvitan
- Active substance
- mitratapide
- Group
- Veterinary medicines
- Marketing authorisation holder
- Janssen Pharmaceutica N.V.
- Status
- Withdrawn
- EU authorisation
- 14 Nov 2006